Marketing & Strategy

Customer-Centric Engagement During COVID-19

Health Industry Hub | April 8, 2020 |
[Total: 1    Average: 4/5]

Navigating the multichannel maze in COVID 19 times to engage healthcare professionals (HCPs) and patients has been challenging for most local marketing, medical and commercial teams.

In the last few weeks, Health Industry Hub gained insights from several clinicians (GPs, specialists and surgeons) on how the COVID-19 pandemic has impacted their day-to-day world in clinics and with their patients. See infographic below.

In overwhelming times, most HCPs are not looking to engage with the field force in one-on-one virtual meetings or phone calls unless there is a compelling reason to do so, for example, clinical trials, virtual advisory boards, new registration / reimbursement of medicines or medical devices.

Instead, HCPs are interested in receiving valuable, cross-functional medical content that is easy to access and is of benefit to them and/or their patients.

Click on the image below to learn more.

Customer engagement during COVID-19. Fill the gap of reduced field force activities. Health Industry Hub combines expertise in delivering digital health content and measuring engagement with 20+ years industry experience. Created by industry for industry. Contact us.


About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

News & Trends - Medical Technology

MedTech News - Siemens Healthineers to acquire Varian in $16.4bn deal

Siemens Healthineers to acquire Varian in $16.4bn deal

Health Industry Hub | August 5, 2020 |

MedTech News: Siemens Healthineers shall acquire Varian Medical Systems for approximately USD$16.4 billion. Since 2012, Siemens Healthineers and Varian have […]

More


News & Trends - Pharmaceuticals

Pharma News - New anti-cancer drug for prostate cancer

New anti-cancer drug for prostate cancer

Health Industry Hub | August 5, 2020 |

Pharma News: A new anti-cancer drug for prostate cancer overcomes the twin problems plaguing researchers for decades. It halts metastasis […]

More


News & Trends - Pharmaceuticals

Pharma News -

Popular high blood pressure drug linked to increased skin cancer risk

Health Industry Hub | August 5, 2020 |

Pharma News: Hydrochlorothiazide, a diuretic, is one of the most prescribed high blood pressure drugs and is used alone or […]

More


News & Trends - Pharmaceuticals

Pharma News - Australian triple therapy for COVID-19 cure and prevention

Australian triple therapy for COVID-19 cure and prevention

Health Industry Hub | August 5, 2020 |

Pharma News: The Centre for Digestive Disease (CDD) Medical Director Professor Thomas Borody says TGA and FDA approved Ivermectin, which […]

More